Parabilis Medicines, Inc. (PBLS)
39.47
+0.46
(+1.18%)
USD |
NASDAQ |
Sep 01, 16:00
39.58
+0.12
(+0.29%)
After-Hours: 20:00
Parabilis Medicines Cash from Operations (Annual) : -123.71M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -123.71M |
| Date | Value |
|---|---|
| December 31, 2024 | -103.63M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Moderna, Inc. | -1.873B |
| Kailera Therapeutics, Inc. | -120.21M |
| Arrowhead Pharmaceuticals, Inc. | 179.55M |
| Oncolytics Biotech, Inc. | -20.11M |
| Sangamo Therapeutics, Inc. | -97.21M |